FEATURED

Grail Hits Unicorn Status with $1 Billion Capital for Blood Cancer Test

Illumina owned startup, Grail has announced that it is in the process of raising more than $1 billion in venture...
Mahboob Imtiyaz • January 7, 2017
xenopat
NEWEST

Xenopat: Your Tumor in a Mouse
Xavier Tadeo • July 28, 2016
academic career pathways
NEWEST

Review: The Surplus of Postdocs
Xavier Tadeo • April 13, 2016
analytica 2018